Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Oct 28:1–12. doi: 10.1080/14760584.2021.1987223

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 Informa UK Limited, trading as Taylor & Francis Group

This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.

PMC Copyright notice

Figure 1. — The genomic organization of SARS-CoV-2 and spike protein structure. (1) The structure of SARS-CoV-2 containing an RNA as genetic material with four distinguished structural proteins like spike glycoprotein (S), membrane protein (M), envelop protein (E), and nucleocapsid (N), (2) the genomic organization of the SARS-CoV-2 with 16 Nsps along with the structural and the accessory proteins gene (from 5ʹ end to 3ʹ end), and (3) spike glycoprotein structure with two subunits S1 and S2 that are targeted by the human enzyme Furin, and it may also cause the development of a syncytium (cell fusion) where S1 contains a receptor binding domain (RBD); S1 has a C-terminal domain (CTD) and an N-terminal domain (NTD)